Literature DB >> 27179789

Targeted inactivation of murine Ddx3x: essential roles of Ddx3x in placentation and embryogenesis.

Chia-Yu Chen1, Chieh-Hsiang Chan1, Chun-Ming Chen2,3, Yin-Shuan Tsai1, Tsung-Yuan Tsai1, Yan-Hwa Wu Lee4,5, Li-Ru You4,3.   

Abstract

The X-linked DEAD-box RNA helicase DDX3 (DDX3X) is a multifunctional protein that has been implicated in gene regulation, cell cycle control, apoptosis, and tumorigenesis. However, the precise physiological function of Ddx3x during development remains unknown. Here, we show that loss of Ddx3x results in an early post-implantation lethality in male mice. The size of the epiblast marked by Oct3/4 is dramatically reduced in embryonic day 6.5 (E6.5) Ddx3x-/Y embryos. Preferential paternal X chromosome inactivation (XCI) in extraembryonic tissues of Ddx3x heterozygous (Ddx3x-/+) female mice with a maternally inherited null allele leads to placental abnormalities and embryonic lethality during development. In the embryonic tissues, Ddx3x exhibits developmental- and tissue-specific differences in escape from XCI. Targeted Ddx3x ablation in the epiblast leads to widespread apoptosis and abnormal growth, which causes embryonic lethality in the Sox2-cre/+;Ddx3xflox/Y mutant around E11.5. The observation of significant increases in γH2AX and p-p53Ser15 indicates DNA damage, which suggests that loss of Ddx3x leads to higher levels of genome damage. Significant upregulation of p21WAF1/Cip1 and p15Ink4b results in cell cycle arrest and apoptosis in Ddx3x-deficient cells. These results have uncovered that mouse Ddx3x is essential for both embryo and extraembryonic development.
© The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27179789     DOI: 10.1093/hmg/ddw143

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  23 in total

1.  Novel alternative ribonucleotide excision repair pathways in human cells by DDX3X and specialized DNA polymerases.

Authors:  Valentina Riva; Anna Garbelli; Federica Casiraghi; Francesca Arena; Claudia Immacolata Trivisani; Assunta Gagliardi; Luca Bini; Martina Schroeder; Antonio Maffia; Simone Sabbioneda; Giovanni Maga
Journal:  Nucleic Acids Res       Date:  2020-11-18       Impact factor: 16.971

2.  Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development.

Authors:  Ashley L Lennox; Mariah L Hoye; Ruiji Jiang; Bethany L Johnson-Kerner; Lindsey A Suit; Srivats Venkataramanan; Charles J Sheehan; Fernando C Alsina; Brieana Fregeau; Kimberly A Aldinger; Ching Moey; Iryna Lobach; Alexandra Afenjar; Dusica Babovic-Vuksanovic; Stéphane Bézieau; Patrick R Blackburn; Jens Bunt; Lydie Burglen; Philippe M Campeau; Perrine Charles; Brian H Y Chung; Benjamin Cogné; Cynthia Curry; Maria Daniela D'Agostino; Nataliya Di Donato; Laurence Faivre; Delphine Héron; A Micheil Innes; Bertrand Isidor; Boris Keren; Amy Kimball; Eric W Klee; Paul Kuentz; Sébastien Küry; Dominique Martin-Coignard; Ghayda Mirzaa; Cyril Mignot; Noriko Miyake; Naomichi Matsumoto; Atsushi Fujita; Caroline Nava; Mathilde Nizon; Diana Rodriguez; Lot Snijders Blok; Christel Thauvin-Robinet; Julien Thevenon; Marie Vincent; Alban Ziegler; William Dobyns; Linda J Richards; A James Barkovich; Stephen N Floor; Debra L Silver; Elliott H Sherr
Journal:  Neuron       Date:  2020-03-04       Impact factor: 17.173

3.  Sexually dimorphic RNA helicases DDX3X and DDX3Y differentially regulate RNA metabolism through phase separation.

Authors:  Hui Shen; Amber Yanas; Michael C Owens; Celia Zhang; Clark Fritsch; Charlotte M Fare; Katie E Copley; James Shorter; Yale E Goldman; Kathy Fange Liu
Journal:  Mol Cell       Date:  2022-05-18       Impact factor: 19.328

4.  Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model.

Authors:  Mariah L Hoye; Lorenzo Calviello; Abigail J Poff; Nna-Emeka Ejimogu; Carly R Newman; Maya D Montgomery; Jianhong Ou; Stephen N Floor; Debra L Silver
Journal:  Elife       Date:  2022-06-28       Impact factor: 8.713

5.  Prospective and detailed behavioral phenotyping in DDX3X syndrome.

Authors:  Lara Tang; Tess Levy; Sylvia Guillory; Danielle Halpern; Jessica Zweifach; Ivy Giserman-Kiss; Jennifer H Foss-Feig; Yitzchak Frank; Reymundo Lozano; Puneet Belani; Christina Layton; Bonnie Lerman; Emanuel Frowner; Michael S Breen; Silvia De Rubeis; Ana Kostic; Alexander Kolevzon; Joseph D Buxbaum; Paige M Siper; Dorothy E Grice
Journal:  Mol Autism       Date:  2021-05-16       Impact factor: 7.509

6.  DDX3X acts as a live-or-die checkpoint in stressed cells by regulating NLRP3 inflammasome.

Authors:  Parimal Samir; Sannula Kesavardhana; Deanna M Patmore; Sebastien Gingras; R K Subbarao Malireddi; Rajendra Karki; Clifford S Guy; Benoit Briard; David E Place; Anannya Bhattacharya; Bhesh Raj Sharma; Amanda Nourse; Sharon V King; Aaron Pitre; Amanda R Burton; Stephane Pelletier; Richard J Gilbertson; Thirumala-Devi Kanneganti
Journal:  Nature       Date:  2019-09-11       Impact factor: 69.504

7.  RNA helicase, DDX3X, is actively recruited to sites of DNA damage in live cells.

Authors:  Michael J Cargill; Alicia Morales; Shashidhar Ravishankar; Edus H Warren
Journal:  DNA Repair (Amst)       Date:  2021-05-18

8.  Social and emotional characteristics of girls and young women with DDX3X-associated intellectual disability: a descriptive and comparative study.

Authors:  Elise Ng-Cordell; Anna Kolesnik-Taylor; Sinéad O'Brien; Duncan Astle; Gaia Scerif; Kate Baker
Journal:  J Autism Dev Disord       Date:  2022-05-10

9.  RNA helicase DDX3 maintains lipid homeostasis through upregulation of the microsomal triglyceride transfer protein by interacting with HNF4 and SHP.

Authors:  Tsung-Yuan Tsai; Wei-Ting Wang; Hao-Kang Li; Wei-Ju Chen; Yu-Hong Tsai; Chi-Hong Chao; Yan-Hwa Wu Lee
Journal:  Sci Rep       Date:  2017-01-27       Impact factor: 4.379

10.  Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment.

Authors:  M R Heerma van Voss; F Vesuna; G M Bol; J Afzal; S Tantravedi; Y Bergman; K Kammers; M Lehar; R Malek; M Ballew; N Ter Hoeve; D Abou; D Thorek; C Berlinicke; M Yazdankhah; D Sinha; A Le; R Abrahams; P T Tran; P J van Diest; V Raman
Journal:  Oncogene       Date:  2017-09-04       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.